Anton Franken

1.5k total citations
28 papers, 881 citations indexed

About

Anton Franken is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Anton Franken has authored 28 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Genetics and 5 papers in Surgery. Recurrent topics in Anton Franken's work include Pituitary Gland Disorders and Treatments (8 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Connective tissue disorders research (7 papers). Anton Franken is often cited by papers focused on Pituitary Gland Disorders and Treatments (8 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Connective tissue disorders research (7 papers). Anton Franken collaborates with scholars based in Netherlands, United Kingdom and United States. Anton Franken's co-authors include Maarten A.D.H. Schalekamp, E. Peperkamp, P.T.V.M. de Jong, F. H. M. Derkx, Marinus A. van den Dorpel, A.H. Jan Danser, Jaap Deinum, A. J. van der Lely, H. P. F. Koppeschaar and Christa C. van Bunderen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, CHEST Journal and Clinical Chemistry.

In The Last Decade

Anton Franken

28 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anton Franken Netherlands 15 458 292 189 152 124 28 881
Carol Stolarski United States 12 457 1.0× 206 0.7× 198 1.0× 153 1.0× 65 0.5× 26 769
Giuseppe Rossi Italy 18 611 1.3× 177 0.6× 95 0.5× 214 1.4× 75 0.6× 27 1.2k
Roberto Catalán Spain 16 402 0.9× 90 0.3× 123 0.7× 126 0.8× 86 0.7× 22 998
Mohd Shazli Draman United Kingdom 21 686 1.5× 93 0.3× 305 1.6× 89 0.6× 54 0.4× 36 1.4k
Ercan Tuncel Türkiye 17 276 0.6× 54 0.2× 143 0.8× 241 1.6× 53 0.4× 41 772
Jin Ook Chung South Korea 14 212 0.5× 71 0.2× 256 1.4× 109 0.7× 40 0.3× 64 718
Adriana Lai Italy 16 760 1.7× 62 0.2× 156 0.8× 50 0.3× 196 1.6× 30 1.1k
Simonetta Bacci Italy 20 415 0.9× 289 1.0× 276 1.5× 244 1.6× 15 0.1× 37 1.2k
Avais Jabbar United Kingdom 9 600 1.3× 198 0.7× 182 1.0× 103 0.7× 10 0.1× 15 901
Nobuo Nyui Japan 15 376 0.8× 638 2.2× 378 2.0× 97 0.6× 17 0.1× 28 1.0k

Countries citing papers authored by Anton Franken

Since Specialization
Citations

This map shows the geographic impact of Anton Franken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Franken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Franken more than expected).

Fields of papers citing papers by Anton Franken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Franken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Franken. The network helps show where Anton Franken may publish in the future.

Co-authorship network of co-authors of Anton Franken

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Franken. A scholar is included among the top collaborators of Anton Franken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Franken. Anton Franken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janus, Guus, et al.. (2024). Bleeding assessment in a large cohort of patients with Osteogenesis Imperfecta. Orphanet Journal of Rare Diseases. 19(1). 61–61. 2 indexed citations
2.
Chaney, Hollis, Elisabeth M. W. Eekhoff, Anton Franken, et al.. (2023). Key4OI Recommendations for Lung Function Guidance in Osteogenesis Imperfecta. CHEST Journal. 163(5). 1201–1213. 2 indexed citations
3.
Flinterman, Linda E., Josephina G. Kuiper, Joke C. Korevaar, et al.. (2020). Impact of a Forced Dose-Equivalent Levothyroxine Brand Switch on Plasma Thyrotropin: A Cohort Study. Thyroid. 30(6). 821–828. 17 indexed citations
4.
Dijk, Fleur S. van, et al.. (2020). Fatigue in adults with Osteogenesis Imperfecta. BMC Musculoskeletal Disorders. 21(1). 6–6. 16 indexed citations
7.
Bunderen, Christa C. van, et al.. (2016). Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults. Pituitary. 19(4). 381–390. 10 indexed citations
8.
9.
Bunderen, Christa C. van, et al.. (2015). Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy. The Journal of Clinical Endocrinology & Metabolism. 100(8). 3132–3139. 19 indexed citations
11.
Bunderen, Christa C. van, Martijn W. Heymans, Anton Franken, et al.. (2014). Effect of long-term GH replacement therapy on cardiovascular outcomes in GH-deficient patients previously treated for acromegaly: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults. European Journal of Endocrinology. 171(6). 717–726. 11 indexed citations
12.
Bunderen, Christa C. van, I. Caroline van Nieuwpoort, Lucia I. Arwert, et al.. (2011). Does Growth Hormone Replacement Therapy Reduce Mortality in Adults with Growth Hormone Deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in Adults. The Journal of Clinical Endocrinology & Metabolism. 96(10). 3151–3159. 95 indexed citations
13.
Kokshoorn, Nieke E, Johannes W. A. Smit, Willy‐Anne Nieuwlaat, et al.. (2011). Low prevalence of hypopituitarism after traumatic brain injury: a multicenter study. European Journal of Endocrinology. 165(2). 225–231. 53 indexed citations
14.
Nieuwpoort, I. Caroline van, Christa C. van Bunderen, Lucia I. Arwert, et al.. (2011). Dutch National Registry of GH Treatment in Adults: patient characteristics and diagnostic test procedures. European Journal of Endocrinology. 164(4). 491–497. 19 indexed citations
15.
Nijenhuis, Marga, Erica L T van den Akker, Anton Franken, et al.. (2001). Familial Neurohypophysial Diabetes Insipidus in a Large Dutch Kindred: Effect of the Onset of Diabetes on Growth in Children and Cell Biological Defects of the Mutant Vasopressin Prohormone1. The Journal of Clinical Endocrinology & Metabolism. 86(7). 3410–3420. 25 indexed citations
17.
Franken, Anton, P. J. Blankestijn, J. A. M. J. L. Janssen, et al.. (1992). Plasma prorenin as an early marker of microvascular disease in patients with diabetes mellitus. Diabetes & Metabolism. 18. 137–143. 33 indexed citations
18.
Franken, Anton, F. H. M. Derkx, Wim C.J. Hop, et al.. (1990). High Plasma Prorenin in Diabetes Mellitus and Its Correlation with Some Complications. The Journal of Clinical Endocrinology & Metabolism. 71(4). 1008–1015. 87 indexed citations
19.
Danser, A.H. Jan, Marinus A. van den Dorpel, Jaap Deinum, et al.. (1989). Renin, Prorenin, and Immunoreactive Renin in Vitreous Fluid From Eyes With and Without Diabetic Retinopathy. The Journal of Clinical Endocrinology & Metabolism. 68(1). 160–167. 236 indexed citations
20.
Franken, Anton, et al.. (1988). Association of high plasma prorenin with diabetic retinopathy. Journal of Hypertension. 6(4). S461–463. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026